8-K
Current Report
Retension Pharmaceuticals, Inc. Filed Acc 0001213900-26-111794
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading ea0309450-8k_retension.htm…